|
|
Volumn 88, Issue 2, 2008, Pages 126-
|
|
LL-3858
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ISONIAZID;
LL 3858;
PYRROLE DERIVATIVE;
RIFAMPICIN;
SUDOTERB;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIMICROBIAL ACTIVITY;
AREA UNDER THE CURVE;
BACTERICIDAL ACTIVITY;
CONCENTRATION RESPONSE;
DRUG CLEARANCE;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG POTENCY;
DRUG POTENTIATION;
DRUG STRUCTURE;
LUNG TUBERCULOSIS;
MINIMUM INHIBITORY CONCENTRATION;
MOUSE;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
TREATMENT DURATION;
ANIMALS;
ANTITUBERCULAR AGENTS;
HUMANS;
ISONICOTINIC ACIDS;
PYRROLES;
TREATMENT OUTCOME;
TUBERCULOSIS;
|
|
EID: 43249100816
PISSN: 14729792
EISSN: None
Source Type: Journal
DOI: 10.1016/S1472-9792(08)70015-5 Document Type: Review |
|
Times cited : (15)
|
|
References (3)
|
